Tag: Mid-cap pharma stocks

BENGALURU: Infosys McCamish Systems (IMS), a subsidiary of Infosys BPM, has agreed to put $17.5 million into a fund to settle pending class-action lawsuits and resolve allegations following a cybersecurity incident in 2023....

In a new note to clients published Friday, BMO chief investment strategist Brian Belski — one of the Street's staunchest bulls who was quick to call the market turnaround back in 2022 — argues...